文献速递胰腺与胆道疾病消化内镜消化道肿瘤与早癌

基于EUS的机器学习模型鉴别主胰管型IPMN与慢性胰腺炎

Indeterminate main pancreatic duct dilation: an endoscopic ultrasound-based machine learning model to distinguish main duct-intraductal papillary mucinous neoplasm from chronic pancreatitis.
PubMed 文献 · Gastrointest Endosc · 2026-04-18

本研究为单中心回顾性研究,纳入123例患者(83例慢性胰腺炎,40例主胰管型IPMN),基于21项EUS特征训练多种机器学习分类器。随机森林模型表现最佳,测试集AUC为0.946,F1分数为0.879;在无结石亚组中仍稳健(AUC 0.830)。该可解释模型有助于在横断面成像不确定时鉴别主胰管扩张的病因。

要点

  • EUS特征(胰管内结节、胰管结石、囊性模式、实质改变)可鉴别MD-IPMN与CP。
  • 随机森林模型测试集AUC 0.946、F1分数0.879,校准良好且有净获益。
  • 无结石亚组中模型仍稳健(AUC 0.830),准确率、精确率、召回率均>0.8。

核心结论

  • 基于EUS特征的可解释机器学习模型能区分MD-IPMN与CP相关的主胰管扩张,包括无结石病例,可能支持横断面成像不确定时的标准化评估。

研究设计与样本

  • 单中心回顾性研究,纳入Johns Hopkins医院2011年12月至2024年9月连续患者,最终分析123例(83例CP,40例MD-IPMN),由两名盲法内镜医师独立评分21项EUS特征,训练多种分类器并进行内部验证和类别不平衡校正。

主要发现

  • 随机森林模型测试集AUC为0.946,F1分数为0.879,校准良好且有净获益。
  • 无结石亚组中模型F1分数为0.878,AUC为0.830,准确率、精确率和召回率均>0.8。
  • 特征归因显示胰管结石、弥漫性小叶化、弥漫性胰管扩张和萎缩是支持CP的主要预测因子。

临床怎么用

  • 在CT或MRI无法明确主胰管扩张病因时,可考虑使用该EUS特征机器学习模型辅助鉴别MD-IPMN与CP。
  • 模型已开发网页界面,便于床旁应用和未来外部验证。

局限性

  • 单中心回顾性研究,样本量有限(123例),需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Main pancreatic duct dilation occurs in both main-duct intraductal papillary mucinous neoplasm (MD-IPMN) and chronic pancreatitis (CP) but has different clinical implications. We developed an EUS feature-based machine learning model to differentiate MD-IPMN from CP when CT or magnetic resonance imaging is indeterminate. METHODS: We conducted a single-center retrospective study of consecutive patients evaluated at Johns Hopkins Hospital (December 2011-September 2024). Surgically confirmed MD-IPMN and clinically and imaging-diagnosed CP with complete preoperative EUS data were included. Two blinded endoscopists independently scored 21 EUS features. Multiple classifiers were trained with internal validation and class imbalance correction. Performance was assessed using cross-validation and an independent test set, with evaluation of calibration, clinical utility, and feature importance. A prespecified stone-negative subgroup analysis was performed. An online tool was implemented to support point-of-care application and future external validation. RESULTS: Among 123 patients (83 CP; 40 MD-IPMN; mean follow-up 42.67 months), key differentiating features included intraductal nodules (2.4% vs 20.0%; P = .003), ductal stones (77.1% vs 2.5%; P < .001), cyst patterns (P < .001), and parenchymal changes (P = .032). Random Forest test performed best (area under the receiver operating characteristic curve [AUC], 0.946; F1-score, 0.879) with good calibration and net benefit. In the stone-negative subgroup, performance remained robust (F1-score, 0.878; AUC, 0.830), with accuracy, precision, and recall each >0.8. Feature attribution identified ductal stones, diffuse lobularity, diffuse duct dilation, and atrophy as major predictors favoring CP. A web-based interface was developed. CONCLUSIONS: An interpretable EUS-based machine learning model differentiates MD-IPMN from CP-associated duct dilation, including stone-negative cases, and may support standardized evaluation when cross-sectional imaging is inconclusive.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Li J, Prabhakaran SD, Ravikumar R, et al. Indeterminate main pancreatic duct dilation: an endoscopic ultrasound-based machine learning model to distinguish main duct-intraductal papillary mucinous neoplasm from chronic pancreatitis. Gastrointest Endosc. 2026. PMID: 42009203. doi:10.1016/j.gie.2026.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。